Further studies indicated that the expression of glycolytic enzymes changes in chronic inflammation mainly via STAT3/c-Myc pathway, and this finding reflects metabolism reprogramming in IBD transition to CRC condition [131]. The gene discussed is STAT3; the disease is colorectal carcinoma.